Clinical trial
Juvista (Avotermin) in Breast Reduction Surgery Scars
NCT00432328 · Renovo, Industry · Terminated
Key facts
| NCT number | NCT00432328 |
|---|---|
| Title | Juvista (Avotermin) in Breast Reduction Surgery Scars |
| Official title | A Double Blind, Placebo Controlled, Randomised Trial to Investigate the Efficacy of Juvista (Avotermin) in the Improvement of Scar Appearance in Patients Undergoing Bilateral Reduction Mammaplasty. |
| Lead sponsor | Renovo, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mammaplasty, Cicatrix |
| Intervention type | Drug |
| Interventions | Avotermin |
| Enrollment | 39 |
| Start date | Oct 1, 2006 |
| First posted | Feb 7, 2007 |
| Last update posted | Jan 13, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: